The IPA, initially formed by eight national companies in November 1999 has now 20 research-based national pharmaceutical companies in its…
Additional Solicitor General was responding to the contentions of pharma companies like Pfizer, Glenmark, Procter and Gamble and Cipla
Glenmark Pharma has received final nod from the USFDA to manufacture and market therapeutical equivalent of Endo Pharmaceutical’s Frova tablets,…
Quick Heal Technologies made a weak stock market debut on Thursday. Quick Heal share price closed 20.73 per cent down…
The novel clinical development candidate, GBR1342 is an antibody based on the company’s proprietary BEAT platform, Glenmark Pharmaceuticals said in…
Glenmark Pharmaceuticals shares gained over 2 per cent in morning trade on Wednesday after the company received a tentative nod…
However, the company cannot sell the product in the US as it is involved in a patent litigation with Sanofi…
Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the US Food & Drug Administration (USFDA) for the Linezolid…
Glenmark and its US arm Glenmark Pharmaceuticals Inc have entered into a settlement agreement with Forest Laboratories LLC, Forest Laboratories…
Glenmark Pharmaceuticals today said it has received tentative approval from the US health regulator for its Lacosamide tablets.
Glenmark expects to obtain approval for the initiation of clinical studies with GBR1302 during this financial year Glenmark Pharmaceuticals S.A.…
Shares of Glenmark Pharmaceuticals rose 5.9 per cent intraday to mark its record high as it received final approval from…
Glenmark Pharmaceuticals today said it has received final approval from the US health regulator to sell oral contraceptive — drospirenone…
Glenmark’s consolidated revenues grew by 11% yoy to Rs 1,660 crore (in line), led by LatAm (+86%) and India (+19%).
Drug firm Glenmark’s generic skin care drug that was under patent litigation infinges patent of Bayer, a US court has…
Glenmark Pharmaceuticals on Wednesday launched ‘affordable’ gliptin for treatment of Type-2 Diabetes mellitus.
Glenmark Pharmaceuticals Inc., US (Glenmark) has been granted final approval by the US Food and Drug Administration for the extended-cycle…
We note three key positives for the stock: 1) Glenmark Pharma (GNP) has stepped up filings in the US, and…